Literature DB >> 808000

Influence of anesthetics on metabolic, functional and pathological responses to regional cerebral ischemia.

J D Michenfelder, J H Milde.   

Abstract

Regional cerebral ischemia was produced by common carotid artery occlusion in gerbils and by middle cerebral artery occlusion in dogs, cats, and squirrel monkeys. Anesthesia was induced with either pentobarbital or halothane and maintained for two to three hours after vessel occlusion. In acute studies, the effect of regional cerebral ischemia on cerebral concentrations of ATP, phosphocreatine, lactate, and pyruvate was determined at the end of this period in gerbils, cats, and squirrel monkeys. In chronic studies, the degree of neurological deficit and size of cerebral infarction were determined 48 hours after a two-hour to three-hour period of vessel occlusion in cats and squirrel monkeys and permanent occlusion in dogs. In gerbils, dogs, and cats, there were no differences in the metabolis, functional, or pathological effects of anesthesia with pentobarbital or halothane. However, in the squirrel monkey, in acute studies the metabolic alterations were significantly less with pentobarbital, and in chronic studies the frequency and magnitude of functional deficits and cerebral infarction were significantly less. We conclude that pentobarbital does provide a degree of protection during regional cerebral ischemia but that such effects are only consistently demonstrable in primates. In nonprimates, we assume that variability in the collateral circulation renders demonstration of significant differences difficult or impossible.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 808000     DOI: 10.1161/01.str.6.4.405

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  9 in total

1.  Differentiated effect of ageing on the enzymes of Krebs' cycle, electron transfer complexes and glutamate metabolism of non-synaptic and intra-synaptic mitochondria from cerebral cortex.

Authors:  R F Villa; A Gorini; S Hoyer
Journal:  J Neural Transm (Vienna)       Date:  2006-09-14       Impact factor: 3.575

Review 2.  Inhalational anesthetics as neuroprotectants or chemical preconditioning agents in ischemic brain.

Authors:  Hideto Kitano; Jeffrey R Kirsch; Patricia D Hurn; Stephanie J Murphy
Journal:  J Cereb Blood Flow Metab       Date:  2006-10-18       Impact factor: 6.200

3.  Effect of ageing and ischemia on enzymatic activities linked to Krebs' cycle, electron transfer chain, glutamate and aminoacids metabolism of free and intrasynaptic mitochondria of cerebral cortex.

Authors:  Roberto Federico Villa; Antonella Gorini; Siegfried Hoyer
Journal:  Neurochem Res       Date:  2009-12       Impact factor: 3.996

Review 4.  Barbiturates in severe head injuries?

Authors:  D Moskopp; F Ries; H Wassmann; J Nadstawek
Journal:  Neurosurg Rev       Date:  1991       Impact factor: 3.042

5.  Investigation of optical neuro-monitoring technique for detection of maintenance and emergence states during general anesthesia.

Authors:  Gabriela Hernandez-Meza; Meltem Izzetoglu; Mary Osbakken; Michael Green; Hawa Abubakar; Kurtulus Izzetoglu
Journal:  J Clin Monit Comput       Date:  2017-02-18       Impact factor: 2.502

Review 6.  Brain protection: physiological and pharmacological considerations. Part II: The pharmacology of brain protection.

Authors:  R Hall; J Murdoch
Journal:  Can J Anaesth       Date:  1990-10       Impact factor: 5.063

7.  Thiopentone induced coma after severe birth asphyxia.

Authors:  J A Eyre; A R Wilkinson
Journal:  Arch Dis Child       Date:  1986-11       Impact factor: 3.791

8.  Barbiturates for cerebral aneurysm surgery. A review of preliminary results.

Authors:  M Belopavlovic; A Buchthal; J W Beks
Journal:  Acta Neurochir (Wien)       Date:  1985       Impact factor: 2.216

9.  ATPases of synaptic plasma membranes from hippocampus after ischemia and recovery during ageing.

Authors:  R F Villa; A Gorini; S Hoyer
Journal:  Neurochem Res       Date:  2002-09       Impact factor: 3.996

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.